About the Institutional Review Board of INTEGRIS Health.
The Institutional Review Board of INTEGRIS Health serves to approve the initiation of and to conduct continuing review of research involving human subjects under the jurisdiction of Federal Wide Project Assurance 3082. This review is conducted to protect the rights of the human subjects in research and in accordance with the terms of the FWA and regulations located in the Code of Federal Regulations Title 45 Part 46 and Title 21 Parts 50 and 56. Federal regulations require a review of the scientific merit of the protocol by the IRB to determine if the risk/benefit ratio is appropriate.
The IRB’s primary function is to protect the rights and welfare of human subjects involved in research and to assist the investigator and the institution in their mutual obligation to comply with all federal, and state regulations and all institutional policies with respect to these subjects. INTEGRIS Health IRB approval must be obtained if any of the following circumstances apply: